Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adenovirus
Findings from Stanford University, Division of Hematology provide new insights into adenovirus
May 18th, 2008
New investigation results, 'Recombinant adenovirus as a methodology for exploration of physiologic functions of growth factor pathways,' are detailed in a study published in Journal of Molecular Medicine. According to recent research published in the Journal of Molecular Medicine, "The use of recombinant adenoviruses (Ad) to express secreted antagonists of growth factors represents a powerful strategy for studying physiologic functions of growth factor pathways in experimental animals. Indeed, a single adenoviral injection can produce characteristic high-level and persistent plasma expression of soluble receptor ectodomains or secreted protein antagonists, allowing highly...
Source: Pharma Investments, Ventures & Law Weekly (2008-05-18)
|
